Takeda Pharmaceutical Co Ltd
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -11.0% | +13.9% | -5.7% | +237.8% | -7.6% | +0.7% | +2.1% | +5.9% | +8.2% | -5.7% | +8.9% | |
| – | -9.6% | -8.2% | -14.4% | +182.8% | -19.1% | +9.9% | -4.4% | -7.5% | +6.7% | -1.5% | +23.1% | |
| – | -30.8% | -29.2% | -7.8% | +138.4% | -9.2% | +51.5% | -12.1% | -37.2% | -14.2% | -15.9% | +55.2% | |
| – | -21.5% | -32.8% | -0.3% | +93.3% | -9.9% | +53.5% | -12.7% | -36.7% | -14.6% | -14.2% | +47.3% | |
| – | -7.8% | +3.3% | -3.6% | +74.7% | +4.8% | +3.5% | -10.9% | -5.9% | +2.3% | +4.0% | +21.4% | |
| – | -3.2% | -10.9% | -5.9% | +363.4% | -23.0% | -0.8% | +13.2% | +15.6% | +22.6% | +0.6% | +15.2% | |
| – | +12,501.5% | -4.5% | +1.8% | +148.1% | +4.1% | +4.9% | +8.9% | +6.9% | +17.7% | -1.1% | – | |
| – | -5.2% | +31.2% | +0.6% | +304.3% | -3.6% | +0.5% | +9.3% | +8.7% | +12.9% | -1.6% | +9.6% | |
| – | -20.9% | +43.4% | -4.8% | +379.2% | -14.2% | -6.3% | -2.3% | +11.8% | +0.1% | -15.0% | -5.4% | |
| – | -13.3% | +32.8% | -13.2% | +316.9% | -7.1% | -4.4% | -3.1% | +1.4% | +3.0% | -6.7% | +5.5% | |
| – | -15.7% | +59.4% | -46.0% | +240.5% | -13.3% | -18.5% | +21.0% | +15.7% | -6.8% | +8.4% | -2.7% | |
| – | +128.5% | +138.6% | -100.0% | +5,471,822.2% | -40.4% | -96.2% | +820.8% | +66.5% | +8.1% | +49.5% | -6.3% | |
| – | +11.9% | +25.9% | -44.4% | +58.8% | -0.3% | +9.7% | +27.5% | +3.9% | +4.1% | -3.6% | +60.0% | |
| – | -100.0% | – | +64.3% | +383.5% | -5.4% | +2.4% | -10.2% | -2.4% | +10.7% | -11.4% | +10.2% | |
| – | -8.8% | -2.8% | +5.4% | +158.3% | -8.5% | +9.5% | +9.9% | +11.8% | +14.5% | -4.6% | +12.6% | |
| – | -4.9% | -0.7% | +3.0% | +0.8% | -12.7% | +10.2% | -2.0% | +4.2% | -9.7% | -14.6% | -10.6% | |
| – | +0.2% | -0.3% | +0.1% | +22.9% | +62.0% | +0.5% | +0.2% | -0.5% | +0.7% | +1.6% | -0.2% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.